Clinical Trial Update: High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 early trial evaluating high-dose topotecan for retinoblastoma with recurrent or refractory vitreous seeds is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinoblastoma

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: Eye & ENT Hospital of Fudan University | Conditions: Retinoblastoma, Retinoblastoma, Recurrent | EARLY_Phase 1 | Status: RECRUITING